Dietary intake, neutrophil fatty acid profile, serum antioxidant vitamins and oxygen radical absorbance capacity in patients with ulcerative colitis

Journal of Nutritional Science and Vitaminology

Volumn 53, Issue 2, 2007, Pages 153-159

  Kawakami, Yuko ^a   Okada, Hiroyuki ^b   Murakami, Yasuko ^c   Kawakami, Takayo ^c   Ueda, Yukiko ^d   Kunii, Daisuke ^e   Sakamoto, Yachiyo ^f   Shiratori, Yasushi ^b   Okita, Misako ^c  

^a Chugoku Gakuen University   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

^c OKAYAMA PREFECTURAL UNIVERSITY   (Japan)

^d NARA WOMEN'S UNIVERSITY   (Japan)

^e Japan Ministry of Education Culture Sports Science and Technology   (Japan)

^f OKAYAMA UNIVERSITY   (Japan)

Author keywords

Antioxidative capacity; Diet; Neutrophil fatty acid; Ulcerative colitis

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ARACHIDONIC ACID; BETA CAROTENE; CARBOHYDRATE; FATTY ACID; ICOSAPENTAENOIC ACID; LINOLEIC ACID; OXYGEN RADICAL; PROTEIN;

ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DIET THERAPY; DIETARY INTAKE; FEMALE; HUMAN; LEUKOCYTE COUNT; LIPID COMPOSITION; MALE; NEUTROPHIL; PHOSPHOLIPID BLOOD LEVEL; RELAPSE; ULCERATIVE COLITIS;

ADULT; ALBUMINS; ALPHA-TOCOPHEROL; ANTIOXIDANTS; BETA CAROTENE; COLITIS, ULCERATIVE; DIET; DIET RECORDS; FATTY ACIDS; FEMALE; HUMANS; MALE; NEUTROPHILS; PHOSPHOLIPIDS; PROTEINS; REACTIVE OXYGEN SPECIES; VITAMIN A; VITAMINS;

EID: 34250641159     PISSN: 03014800     EISSN: 18817742     Source Type: Journal    
DOI: 10.3177/jnsv.53.153     Document Type: Article

References (32)

1. Geerling BJ, Stockbrugger RW, Brummer R-JM. 1999. Nutrition and inflammatory bowel disease: an update. Scand J Gastroenterol 230: 95-105.
2. Gassull MA. 2003. Nutrition and inflammatory bowel disease: its relation to pathophysiology, outcome and therapy. Dig Dis Sci 21: 220-227.
3. Sakamoto N, Kono S, Wakai K, Fukuda Y, Satomi M, Shimoyama T, Inaba Y, Miyake Y, Sasaki S, Okamoto K, Kobashi G, Washio M, Yokoyama T, Date C, Tanaka H, The Epidemiology Group of the Research Committee on Inflammatory Bowel Disease in Japan. 2005. Dietary risk factors for inflammatory bowel disease: a multicenter case-control study in Japan. Inflamm Bowel Dis 11: 154-163.
4. Geerling BJ, Dagnelie PC, Badart-Smook A, Russel MG, Stockbrugger RW, Brummer R-JM. 2000. Diet as a risk factor for the development of ulcerative colitis. Am J Gastroenterol 95: 1008-1013.
5. Fernandez-Banares F, Hinojosa J, Sanchez-Lombrana JL, Navarro E, Martinez-Salmeron JF, Garcia-Puges A, Gonzalez-Huix F, Riera J, Gonzalez-Lara V, Dominguez-Abascal F, Gine JJ, Moles J, Gomollon F, Gassull MA. 1999. Randomized clinical trial of Plantago ovata seeds (dietary fiber) as compared with mesalamine in maintaining remisson in ulcerative colitis. Am J Gastroenterol 94: 427-433.
6. Jowett SL, Seal CJ, Pearce MS, Phillips E, Gregory W, Barton JR, Welfare MR. 2004. Influence of dietary factors on the clinical course of ulcerative colitis: a prospective cohort study. Gut 53: 1479-1484.
7. Bitton A, Peppercorn MA, Antonioli DA, Niles JL, Shah S, Bousvaros A, Ransil B, Wild G, Cohen A, Edwardes MD, Stevens AC. 2001. Clinical, biological, and histologic parameters as predictors of relapse in ulcerative colitis. Gastroenterology 120: 13-20.
8. Seidner DL, Lashner BA, Brzezinski A, Banks PL, Goldblum J, Fiocchi C, Katz J, Lichtenstein GR, Anton PA, Kam LY, Garleb KA, Demichele SJ. 2005. An oral supplement enriched with fish oil, soluble fiber, and antioxidants for corticosteroid sparing in ulcerative colitis: a randomized, controlled trial. Clin Gastroenterol Hepatol 3: 358-369.
9. Calder PC. 2004. n-3 Fatty acids, inflammation, and immunity-relevance to postsurgical and critically ill patients. Lipids 39: 1147-1161.
10. D'Odorico A, Bortolan S, Cardin R, D'Inca' R, Martines D, Ferronato A, Sturniolo GC. 2001. Reduced plasma antioxidant concentrations and increased oxidative DNA damage in inflammatory bowel disease. Scand J Gastroenterol 36: 1289-1294.
11. Schachter H, Kirsner JB. 1975. Definitions of inflammatory bowel disease of unknown etiology. Gastroenterology 68: 591-600.
12. Seo M, Okada M, Yao T, Ueki M, Arima S, Okumura M. 1992. An index of disease activity in patients with ulcerative colitis. Am J Gastroenterol 87: 971-976.
13. Suzuki K, Sasagawa T, Okita M, Fujiwara Y, Mori K, Saito M, Abe Y. 1996. Development of new simplified-food frequency method for use in the surveillance on lifestyle in order to promote healthy condition in Okayama Prefecture, computed by Microsoft Excel. Bull Fac Health Welfare Sci Okayama Prefect Univ 3: 143-153.
14. Bligh EG, Dyer WJ. 1959. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37: 911-917.
15. Okita M, Tomioka K, Ota Y, Sasagawa T, Osawa T, Sakai N, Kawaguchi M, Itoshima T. 2003. Arachidonic acid in mononuclear cells and its clinical significance in HCV cirrhotic patients. Nutrition 19: 727-732.
16. Milne DB, Botnen J. 1986. Retinol, α-tocopherol, lycopene, and α- and β-carotene simultaneously determined in plasma by isocratic liquid chromatography. Clin Chem 32: 874-876.
17. Cao G, Prior RL. 1999. Measurement of oxygen radical absorbance capacity in biological samples. Method Enzymol 299: 50-62.
18. Carletto A, Bellavite P, Guarini P, Biasi D, Chirumbolo S, Caramaschi P, Bambara LM, Corrocher R. 1996. Changes of fatty acid composition and oxidative metabolism of human neutrophils migrating into an inflammatory exudate. Inflammation 20:123-137.
19. Hawkey CJ, Boughton-Smith NK, Whittle BJ. 1985. Modulation of human colonic arachidonic acid metabolism by sulfasalazine. Dig Dis Sci 30: 1161-1165.
20. Peskar BM, Dreyling KW, May B, Schaarschmidt K, Goebell H. 1987. Possible mode of action of 5-aminosalicylic acid. Dig Dis Sci 32 (Suppl): 51S-56S.
21. 4. Prostaglandins 34: 783-795.
22. Moghaddami N, Costabile M, Grover PK, Jersmann HP, Huang ZH, Hii CS, Ferrante A. 2003. Unique effect of arachidonic acid on human neutrophil TNF receptor expression: up-regulation involving protein kinase C, extracellular signal-regulated kinase, and phospholipase A2. J Immunol 171: 2616-2624.
23. 2 in colonic mucosa of patients with Crohn's disease and ulcerative colitis. Gut 35: 1593-1598.
24. Zarini S, Gijon MA, Folco G, Murphy RC. 2006. Effect of arachidonic acid reacylation on leukotriene biosynthesis in human neutrophils stimulated with granulocyte-macrophage colony-stimulating factor and formylmethionyl-leucyl- phenylalanine. J Biol Chem 281: 10134-10142.
25. Samuelsson B. 1983. Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation. Science 220: 568-575.
26. James MJ, Gibson RA, Cleland LG. 2000. Dietary polyunsaturated fatty acids and inflammatory mediator production. Am J Clin Nutr 71(Suppl): 343S-348S.
27. O'Morain C, Tobin A, McColl T, Suzuki Y. 1990. Fish oil in the treatment of ulcerative colitis. Can J Gastroenterol 4: 420-423.
28. Andoh A, Tsujikawa T, Ishizuka I, Araki Y, Sasaki M, Koyama S, Fujiyama Y. 2003. n-3 fatty acid-rich diet prevents early response of interleukin-6 elevation in trinitrobenzene sulfonic acid-induced enteritis. Int J Mol Med 12: 721-725.
29. Oku T. 2004. Dietary reference intake for Japanese (2005): Carbohydrate and dietary fiber. Rinshou Eiyou (Jap J Clin Nutr, Tokyo) 105: 837-839.
30. Fernandez-Bamares F, Abad-Lacruz A, Xiol X, Gine JJ, Dolz C, Cabre E, Esteve M, Gonzalez-Huix F, Gassull MA. 1989. Vitamin status in patients with inflammatory bowel disease. Am J Gastroenterol 84: 744-748.
31. Nielsen SE, Vainer B, Nielsen OH. 2004. Comparative studies of superoxide production by microbial wall product-primed neutrophils in ulcerative colitis. Dig Dis Sci 49: 878-882.
32. Keshavarzian A, Sedghi S, Kanofsky J, List T, Robinson C, Ibraham C, Winship D. 1992. Excessive production of reactive oxygen metabolites by inflamed colon: analysis by chemiluminescence probe. Gastroenterology 103: 177-185.